Type 2 congenital long QT syndrome (LQT-2) is linked to mutations in the human ether a-go-go-related gene (HERG) and is characterized by rate-corrected QT interval (QTc) prolongation, ventricular arrhythmias, syncope, and sudden death. Recognized triggers of these cardiac events include emotional and acoustic stimuli. Here we investigated the repeated occurrence of fever-induced polymorphic ventricular tachycardia and ventricular fibrillation in 2 LQT-2 patients with A558P missense mutation in HERG. ECG analysis showed increased QTc with fever in both patients. WT, A558P, and WT+A558P HERG were expressed heterologously in HEK293 cells and were studied using biochemical and electrophysiological techniques. A558P proteins showed a trafficking-deficient phenotype. WT+A558P coexpression caused a dominant-negative effect, selectively accelerated the rate of channel inactivation, and reduced the temperature-dependent increase in the WT current. Thus, the WT+A558P current did not increase to the same extent as the WT current, leading to larger current density differences at higher temperatures. A similar temperature-dependent phenotype was seen for coexpression of the trafficking-deficient LQT-2 F640V mutation. We postulate that the weak increase in the HERG current density in WT-mutant coassembled channels contributes to the development of QTc prolongation and arrhythmias at febrile temperatures and suggest that fever is a potential trigger of life-threatening arrhythmias in LQT-2 patients.
Introduction
Congenital long QT syndrome (LQTS) is a genetic disease characterized by delayed cardiac repolarization and prolongation of the QT interval on the ECG. LQTS displays an autosomal dominant (Romano-Ward syndrome) or recessive (Jervell LangeNielsen syndrome) inheritance pattern. To date, 10 types of LQTS are known, and each type is linked to mutations in a gene encoding a cardiac ion channel or accessory or regulatory subunits (1) . Mutations in the human ether a-go-go-related gene (HERG) are responsible for the type 2 LQTS (LQT-2) (2) . HERG encodes the α subunit for the rapidly activating, delayed rectifier K + current (I Kr ). I Kr , an outward K + current during phases 2 and 3 of the cardiac action potential, plays an important role in cardiac repolarization (3, 4) .
Nearly 300 HERG mutations are linked to LQT-2, and a small number of these mutations have been heterologously expressed to study the mechanism by which they cause LQT-2. HERG mutations are found to reduce I Kr , mostly due to deficient trafficking of incorrectly folded mutant channel proteins from the ER to the cell membrane (5, 6) . The incorrectly folded mutant proteins are retained in the ER through the actions of quality control systems and kept from reaching the cell membrane to form HERG channels (7) . Other mechanisms by which HERG mutations reduce I Kr in LQT-2 include abnormal HERG protein synthesis or altered gating or permeation properties of mutant HERG channels in the cell membrane (7) . Regardless of the underlying mechanism, I Kr reduction results in delayed cardiac repolarization and prolongation of the action potential duration, which is represented as prolongation of the QT interval on the ECG (8) .
LQTS is associated with polymorphic ventricular tachycardia (torsades de pointes; TdP) and ventricular fibrillation (VF), leading to syncope, seizure, and sudden death. Genotype-phenotype correlation studies have revealed gene-specific triggers that may precipitate such cardiac events in LQTS (9) . Auditory stimuli and emotional stress are well-known triggers of cardiac events in LQT-2 patients with HERG mutations (9, 10) . Previously, fever (body temperature elevated above 38°C) (11) has not been recognized as a trigger of cardiac events in LQTS. In this study, we describe 2 closely related, adult LQT-2 patients with the A558P HERG missense mutation, who suffered from fever-induced QT prolongation, TdP, and VF. We hypothesized that the A558P mutation affects the HERG channel function in a temperaturedependent manner. To test this hypothesis, we analyzed the effects of the A558P mutation on HERG channel protein expression and studied the biophysical properties of mutant channel currents at 23°C, 35°C, and 40°C.
Results
Genetic analysis. We previously described the A558P HERG mutation in a genetic screening study (12) . The index patient was a 22-year-old female of mixed European descent (II-1) who died suddenly upon arousal from sleep by an alarm clock ( Figure 1A ). Mutation analysis of HERG in 15 family members from 3 consecutive generations identified 3 heterozygous carriers of a missense mutation (G to C nucleotide change, at position 1,672 of HERG; Figure 1B ), substituting the amino acid alanine (A) for proline (P) at codon 558 of the transmembrane S5 segment of the HERG channel protein ( Figure 1C ). Linkage analysis excluded a role for the other 2 most common genetic loci of LQTS, type 1 (KCNQ1 gene) and type 3 (SCN5A gene). Generation I consisted of 10 siblings, but only 1 patient (I-1) carried the A558P mutation (12) . This finding suggested that this mutation had occurred de novo in patient I-1. Patients I-1 and II-4 are reported in this study. To date, patient II-2 remains asymptomatic with β-blocker treatment, and ECGs during fever have never been obtained.
Patient I-1. Patient I-1, a 68-year-old male, was diagnosed with Romano-Ward syndrome in 1984 and was treated with the β-blocker alprenolol (100 mg twice daily). He experienced syncope during a Second World War bombardment in 1945. Patient I-1 presented to the emergency department because of 2 episodes of syncope accompanied by fever, cough, and a sore throat since 1 day before admission. Physical examination revealed fever of 39.7°C without localizing symptoms. Blood tests, urine analysis, chest roentgenogram, and echocardiography were normal. Figure 2A shows lead II of the ECG on admission, with sinus rhythm (85 bpm), normal conduction intervals, and a prolonged rate-corrected QT interval (QTc) duration of 540 ms. His prior baseline ECG showed no abnormalities except for a prolonged QTc of 504 ms (data not shown). Shortly after admission, 4 episodes of TdP and VF were observed ( Figure 2B ), occasionally requiring defibrillation (13) . Treatment with alprenolol was continued, and immediate treatment with antipyretics (acetaminophen), oral broad-spectrum antibiotics (amoxicillin/clavulanate), and intravenous K + and Mg 2+ was initiated. The body temperature normalized 8 days after admission. Repeated blood cultures were negative, and no cause for the fever was found. The patient was discharged, and advised to return immediately if fever recurred. Four months later, he returned to a different hospital with fever of 40°C due to a urinary tract infection. During this episode, he experienced VF, requiring defibrillation, and a cardioverter-defibrillator (ICD) was implanted.
Patient II-4. Patient II-4, a 41-year-old male and the son of patient I-1, was admitted after an episode of syncope with TdP and VF documented by the paramedics. An hour before the syncope, he had experienced rigor. This patient had also been diagnosed with Romano-Ward syndrome in 1984. He had been asymptomatic on β-blocker treatment (metoprolol, 100 mg once daily), with a prior baseline ECG showing a prolonged QTc of 480 ms and no further abnormalities. Physical examination after resuscitation revealed fever of 38.5°C and an infected wound on digit III of the right foot. Laboratory tests showed leukocytosis (16,700/mm 3 ). His ECG on admission showed normal sinus rhythm (64 bpm), normal conduction intervals, and a prolonged QTc of 545 ms. Flucloxacillin treatment normalized the body temperature 2 days after admission, and the foot wound healed. An ICD was implanted.
QTc analysis. QTc durations during 2 febrile episodes and following resumption of normothermia (body temperature below 38°C) (11) were performed on patients I-1 and II-4. Body temperature during each ECG recording was assessed by tympanic membrane (ear) temperature measurements, along with measurements of serum K + levels within 1 hour ( Figure 2C , left panel). Repeated ECGs of patient I-1 showed QTc lengthening at higher body temperatures (r = 0.78; P < 0.05). Repeated ECGs of patient II-4 revealed a similar pattern of temperature-dependent changes in QTc (r = 0.93; P < 0.01). The linear fits for both patients were nei- ther different (P = 0.72 for intercepts; P = 0.73 for slopes) nor was the location of the fits when plotted with a common slope (covariance analysis, P = 0.64). This justified representation of the relation between QTc and body temperature for both patients with a common slope ( Figure 2C , right panel). Previously, QT shortening had been reported during hyperthermia in patients without LQTS (14) . To study the relation between body temperature and cardiac repolarization in patients without LQTS, QTc durations during fever and following resumption of normothermia were analyzed from 9 control patients (average age 48.9 ± 6.5 years) who were admitted for the treatment of a febrile episode ( Figure 2C, right panel) . In control patients, the average body temperature decreased from 39.6 ± 0.3°C during fever to 37.5 ± 0.3°C after recovery. QTc duration increased from 422 ± 9 ms during fever to 436 ± 6 ms after recovery. Thus, QTc duration in both LQT-2 patients increased significantly with rising temperature (15 ms/°C; P < 0.001) but decreased significantly in control patients (-6 ms/°C; P < 0.01).
A558P HERG expression. HERG mutations generally lead to deficient trafficking of incorrectly folded mutant channel proteins from the ER to the cell membrane (5, 6). To test whether the A558P mutation also leads to deficient trafficking of HERG proteins, western blot analysis was performed in HEK293 cells, which were transiently transfected with HERG cDNA to express WT or A558P HERG channels. Cells expressing WT HERG showed 2 separate protein bands on western blot, representing normal intracellular processing of the channel proteins ( Figure 3A) . The lower band (135-kDa molecular weight) represents immature core-glycosylated HERG proteins located in the ER, and the upper band (155 kDa) represents mature complexly glycosylated channel proteins located mostly in the cell membrane (15) . This is characteristic for WT HERG proteins that traffic from the ER to the cell membrane through the Golgi apparatus, where they undergo complex glycosylation (7). In contrast, cells expressing A558P HERG exhibited only the lower immature band, characteristic for trafficking-deficient mutant HERG proteins that are retained in the ER, and failed to undergo complex glycosylation in the Golgi apparatus.
To confirm loss of HERG current with the A558P mutation, HERG tail currents (I tail ) were measured from HEK293 cells expressing WT or A558P channels using the patch-clamp technique. The cells were depolarized from a holding potential of -80 mV to 20 mV for 5 seconds, followed by a hyperpolarizing step to -120 mV for 3 seconds to elicit large amplitude I tail ( Figure 3B ). The depolarizing step induced an outward HERG current that partially inactivated, and following the hyperpolarizing step, an inward I tail was present as channels recovered quickly from inactivation and then gradually closed (16) . I tail measurements were consistent with the western blot data ( Figure 3B ). WT channels displayed typical I tail , while only small amplitude I tail could be recorded from cells expressing A558P (150 ± 19 and 5 ± 1 pA/pF, respectively; P < 0.001).
Reducing cell culture temperature or incubating cells with highaffinity HERG channel-blocking drugs (e.g., E-4031) are known to correct the deficient trafficking of most mutant HERG channel proteins to increase their expression on the cell membrane (5) . Although the mechanism is incompletely understood, lower cell culture temperatures or binding of HERG channel-blocking drugs may stabilize intermediate folding states of the mutant proteins and promote their export out of the ER (7). However, trafficking of the A558P proteins could not be corrected by reducing the cell culture temperature to 27°C for 24 hours ( Figure 3 , C and D). Incubation of cells for 24 hours with 10-μmol/l E-4031 resulted in the occurrence of a faint, mature protein band on western blot, suggesting limited correction of the trafficking-deficient phenotype of the A558P proteins. Incubation with E-4031, followed by drug washout for 1-2 hours, also led to a small increase of I tail density (14 ± 1 pA/pF and 5 ± 1 pA/pF for A558P cultured with or without E-4031, respectively; P < 0.05). To verify adequate washout of E-4031 (to exclude for the possibility that mutant currents were small because they were blocked by E-4031), we also incubated cells expressing WT HERG channels with 10-μmol/l E-4031. No difference in I tail density was seen between WT channels incubated with or without E-4031 (150 ± 19 and 155 ± 18 pA/pF, respectively; Figure 3E ), confirming adequate washout of E-4031. The I tail densities are summarized in Figure 3E . Unfortunately, because the amplitudes were small, detailed biophysical analysis of A558P currents could not be performed.
Coexpression of WT and A558P.
Since patients I-1 and II-4 are heterozygous for the A558P mutation, they carry both WT and mutant HERG alleles. Therefore, we determined whether the A558P mutant, HERG-encoded subunit proteins coassemble with WT subunit proteins, thereby disrupting the trafficking of WT proteins to the cell membrane (dominant-negative effect). For this, we coexpressed WT and A558P HERG in HEK293 cells. Western blot analysis of cells transfected with 3-μg or 1.5-μg WT cDNA showed both HERG protein bands ( Figure 4A ). In contrast, cells cotransfected with 1.5-μg WT and 1.5-μg A558P cDNA displayed the immature band with minimal or no mature protein band, indicating a dominantnegative effect of the A558P mutation on the trafficking of WT proteins. I tail densities of cells coexpressing WT+A558P (52 ± 12 pA/pF) were significantly reduced (P < 0.01) compared with cells expressing 3-μg WT (144 ± 13 pA/pF) or 1.5-μg WT cDNA (92 ± 3 pA/pF) ( Figure 4 , B and C), confirming the dominant-negative effect.
The rate of HERG protein intracellular turnover, which includes its trafficking, is slow in heterologous expression (approximately 11 hours in HEK293 cells) (17) and may be even slower in cardiac myocytes (18) . In contrast, the time course of clinical events was fast (i.e., arrhythmia in patient II-4 occurred 1 hour after experiencing rigor). Therefore, altered expression of A558P HERG proteins during fever, leading to further disruption of WT protein trafficking, was not considered as a likely mechanism of fever-induced arrhythmia. However, in additional experiments, we cultured cells expressing A558P at 40°C to mimic fever. Similar to culture at 37°C and 27°C, western blot analysis showed only an immature band (data not shown), indicating that the expression of A558P proteins is not changed at 40°C.
Effect of temperature on WT and WT+A558P currents. Coexpression of WT HERG with A558P HERG showed a dominant-negative effect of the A558P mutation on the trafficking of WT HERG proteins, represented by loss of the mature band on western blot and reduction of I tail densities. Next, we studied whether the presence of the A558P mutant subunits also affected the function of the WT HERG channel and whether this effect was temperaturedependent. While the effect of temperature on protein trafficking was studied by altering the cell culture temperature, the effect of temperature on channel function was studied by altering the current recording temperature in the cell perfusion chamber. To study channel function, we measured gating properties (current density, activation, inactivation, recovery from inactivation, and deactivation) of WT and heteromeric WT+A558P mutant channels at 23°C, 35°C, and 40°C recording temperature.
Current density. Figure 5A illustrates representative I tail from WT and WT+A558P channels at different recording temperatures. Each temperature increase was achieved within 30 seconds. From -80 mV, cells were depolarized to 20 mV for 5 seconds and then repolarized to -50 mV for 3 seconds to measure I tail ( Figure 5A ). As shown in Fig- ure 5B, I tail densities of both WT and WT+A558P channels increased with rising temperatures (89 ± 7, 150 ± 11, and 173 ± 15 pA/pF for WT at 23°C, 35°C, and 40°C versus 26 ± 3, 31 ± 4, and 36 ± 5 pA/pF for WT+A558P at 23°C, 35°C, and 40°C, respectively; P < 0.005). However, compared with WT channels, the temperature-dependent increase of I tail density was significantly smaller for WT+A558P channels (60 ± 11 and 23 ± 6 pA/pF for WT from 23°C to 35°C and 35°C to 40°C versus 7 ± 1 and 5 ± 1 pA/pF for WT+A558P from 23°C to 35°C and 35°C to 40°C, respectively; P < 0.001). Thus, at each temperature, the heteromeric WT+A558P channel current was smaller than WT channel current, and the temperature-dependent increase in HERG current density for heteromeric channels was a small fraction of that found for WT channels. Taken together, these findings led to a larger difference in I tail density between WT and WT+A558P channels at higher temperatures ( Figure 5C ).
To study whether other trafficking-deficient HERG mutations show a similar temperature-dependent phenotype to A558P, we studied the effect of temperature on I tail density of WT HERG coexpressed with the F640V mutation (WT+F640V channel). F640V, first associated with LQT-2 in a genetic screening study (19) , is a missense mutation, substituting the amino acid phenylalanine (F) for valine (V) at codon 640 of the transmembrane S6 segment of the HERG channel protein. We previously showed that, similar to A558P, (a) F640V homomeric channels have a trafficking-deficient phenotype; (b) their deficient trafficking is not correctable by culture at 27°C; and (c) coexpression of F640V with WT HERG imposes a dominant-negative effect (5) . As shown in Figure 5 , B and C, I tail densities of cells coexpressing WT+F640V were significantly reduced compared with cells expressing WT (P < 0.001). I tail densities of WT+F640V channels increased with rising temperatures (12 ± 2, 25 ± 4, and 28 ± 4 pA/pF at 23°C, 35°C, and 40°C, respectively; P < 0.005). However, compared with WT, the temperaturedependent increase of I tail density was significantly smaller for the WT+F640V channels (13 ± 2 and 3 ± 1 pA/pF from 23°C to 35°C and 35°C to 40°C, respectively; P < 0.001). Similar to WT+A558P channels, this led to a larger difference in I tail density between WT and WT+F640V channels at higher temperatures ( Figure 5C) .
Activation. Figure 6A shows the voltage-dependence of activation for WT and WT+A558P channels. To study activation, cells were depolarized from -80 mV to 60 mV in 10 mV increments for 5 seconds (prepulse), followed by a test pulse to -50 mV for 5 seconds to measure I tail ( Figure 6A, inset) . I tail values were normalized to maximum value, averaged, and plotted as a function of the prepulse voltage. Corresponding current-voltage curves were fitted to a Boltzmann equation to determine the membrane potential of half-maximal activation (V 1/2 ) and the slope factors of activation. Raising the temperature shifted the V 1/2 toward more negative potentials in equal measures in both cell groups (-18 ± 3, -32 ± 3, and -38 ± 4 mV for WT at 23°C, 35°C, and 40°C versus -19 ± 2, -30 ± 2, and -35 ± 4 mV for WT+A558P at 23°C, 35°C, and 40°C, respectively; P < 0.001) but did not affect the slope factor values (7.1 ± 0.4, 6.5 ± 0.5, and 7.0 ± 0.7 for WT at 23°C, 35°C, and 40°C versus 7.7 ± 0.2, 7.2 ± 0.3, and 7.4 ± 0.3 for WT+A558P at 23°C, 35°C, and 40°C, respectively). These data indicate earlier activation of both WT and WT+A558P channels at higher temperatures. At each temperature, there was no difference in V 1/2 or slope factor between WT and WT+A558P channels.
Inactivation. Figure 6B shows the voltage-dependence of inactivation for WT and WT+A558P channels. To study inactivation, cells were depolarized from -80 mV to 50 mV for 1.5 seconds, followed by hyperpolarization to -100 mV for 5 milliseconds, and next stepped to test pulses between -20 and 60 mV in 10 mV decrements for 1.5 seconds (Figure 6B, inset) . Time constants of inactivation were calculated by fitting the decay of I tail during the test pulses to a single exponential function. The data indicate that inactivation is accelerated (a) at more depolarized membrane potentials; (b) at higher temperatures; and (c) in the presence of A558P (P < 0.05 for comparison at all tested voltages). Accelerated inactivation suggests a further reduction of HERG current in the WT+A558P channels, due to faster closing of the channels after activation.
Recovery from inactivation. Figure 6C shows the voltage-dependence of recovery from inactivation. To study recovery from inactivation, cells were depolarized from -80 mV to 50 mV for 1.5 seconds, followed by hyperpolarizing test pulses between -100 and -20 mV in 10 mV increments for 3 seconds (Figure 6C, inset) . The initial phase of I tail during the test pulses reflects recovery from inactivation and was fitted to a single exponential function. Due to the fast biophysical properties of I tail at 35°C and 40°C, only time constants for pulses between -70 and -20 mV could be analyzed. At 23°C, WT+A558P channels recovered significantly faster at -30 and -20 mV compared with WT (time constants, 8.1 ± 0.4 ms and 7.9 ± 0.4 ms for WT at -30 and -20 mV versus 6.9 ± 0.2 ms and 6.6 ± 0.3 ms for WT+A558P; P < 0.01). At 35°C, there was no difference between the cell groups. At 40°C, recovery of WT+A558P channels became slower at -70 and -60 mV compared with WT (time constants, 1.8 ± 0.2 ms and 2.5 ± 0.3 ms for WT at -70 and -60 mV vs. 2.7 ± 0.2, 3.0 ± 0.2 ms for WT+A558P; P < 0.01). Although the differences are small, these data suggest an abnormal response of recovery rates to changing temperature in the WT+A558P channels.
Deactivation. Figure 6D shows the voltage dependence of the fast and slow time constants of deactivation. The same voltageclamp protocol as for recovery from inactivation was used, except that the decay of I tail was fit to a double-exponential function to obtain fast and slow time constants of deactivation. In WT and WT+A558P channels, deactivation time constants decreased at more negative membrane potentials. Increasing temperature accelerated the fast and slow time constants, but the effect was small. At each temperature, the presence of A558P did not alter the response of the WT channels.
Discussion
Fever has not been recognized as a trigger of cardiac events in LQTS. In Brugada syndrome (BrS), fever is an established trigger of cardiac events (20) (21) (22) . BrS is another inherited cardiac disease, leading to ventricular tachycardia, VF, and sudden death. In a subset of patients, BrS is linked to mutations in SCN5A, the gene that encodes the cardiac Na + channel, which carries depolarizing Na + current (I Na ) during the cardiac action potential. BrS-related mutations in SCN5A reduce I Na , thereby impairing cardiac depolarization (23) . A possible biophysical basis of the increased risk of arrhythmia during fever was revealed by patch-clamp studies of BrS-linked SCN5A mutations conducted at near-physiologic temperatures. These studies showed temperature-sensitive biophysical properties of mutant Na + channels that reduced I Na compared with studies conducted at room temperature (24, 25) . Thus, the reduction of I Na at febrile temperatures is thought to increase arrhythmogenicity in BrS patients.
In this study, we described 2 related LQT-2 patients with the A558P HERG missense mutation who experienced syncope, TdP, and VF during recurrent fever. ECG analysis during fever and following resumption of normothermia revealed QTc lengthening with rising body temperature in both patients. In healthy subjects, Karjalainen and Viitasalo showed that the QT interval significantly shortened during fever (26) . Accordingly, we observed a significant decrease of QTc duration with rising body temperature in control patients without LQTS. Indeed, experiments in canine cardiac ventricular preparations have reported action potential shortening at 40°C (27) , indicating faster cardiac repolarization at higher temperatures and providing support for the clinical observations. Based on this sharp contrast in QTc response to rising body temperature between the 2 LQT-2 patients and control subjects, we hypothesized that the A558P mutation affects HERG channel function in a temperature-dependent manner. To test this hypothesis, we studied the effect of temperature on heterologously expressed WT and A558P containing mutant HERG channels. The key new findings are (a) A558P homomeric channels showed a severe trafficking-deficient phenotype; (b) the trafficking of A558P homomeric channels was not temperature-dependent (not correctable by culture at 27°C or 40°C); (c) the deficient trafficking could only be minimally corrected by incubation with E-4031; (d) coexpression of WT+A558P HERG revealed that the mutation imposes a dominant-negative effect; (e) the normal increase in WT HERG current density at higher temperatures was reduced by coexpression of A558P subunits; and (f) A558P coexpressed with WT selectively accelerated the inactivation rates. A558P had little or no effect on HERG channel activation, recovery from inactivation, or deactivation. Our findings are in agreement with previous studies of WT HERG currents measured at room temperature and near-physiologic temperature (16, 28) . We believe this is the first report studying WT and mutant HERG currents at 40°C.
HERG mutations are thought to decrease I Kr to cause LQT-2, mostly by deficient trafficking of mutant channel proteins to the cell membrane (5) . The coassembly of mutant subunits with WT subunits also can lead to the formation of dysfunctional channel tetramers in the cell membrane (2) . While abnormal trafficking results in decreased number of functional HERG channels in the cell membrane, the formation of dysfunctional tetramers results in the presence of channels that may have altered gating or ion permeability properties (7) . Ion channel gating is a complex, multistep process, involving multiple different conformational states of the channel protein. The rate of the gating process is temperature sensitive, and it is increased at higher temperatures (28) . The presence of mutant subunits in the tetrameric HERG channel may alter the normal temperature sensitivity of gating. In the present study, we coexpressed WT+A558P HERG in HEK293 cells. Although we did not selectively label the individual subunits to assess coassembly biochemically (29) , the marked reduction in current density, along with the selective acceleration of inactivation, provides strong evidence for coassembly of WT and A558P subunits. Compared to WT channels, HERG current density in coassembled WT+A558P channels was reduced 77% at 35°C. In the computer simulation model of the ventricular action potential developed by Luo and Rudy, a 75% reduction in I Kr led to an approximately 17% increase in the action potential duration at physiological temperatures (30).
Furthermore, although both WT and WT+A558P current densities increased with rising temperatures, for WT+A558P channels this increase was small compared with that found with WT channels. Since current densities of the depolarizing cardiac Na + and L-type Ca 2+ currents also are significantly greater at higher temperatures (24, 25, 31) , we speculate that failure of repolarizing WT+A558P HERG currents to adequately increase at higher temperatures alters the balance between depolarizing and repolarizing currents in favor of depolarization. This will lead to a further delay in cardiac repolarization during fever. The increased rate of channel inactivation would also favor a further reduction in WT+A558P HERG current to further delay repolarization.
The importance of I Kr for maintaining an adequate balance between depolarizing and repolarization during hyperthermia has been previously studied in isolated canine left ventricular M cells and Purkinje fiber preparations (32) . When HERG channels were blocked by pretreatment with E-4031, elevation of recording temperature into the fever range (up to 40°C) induced prolongation of action potential duration and triggered early afterdepolarizations (EADs). EADs are thought to be responsible for the initiation of TdP (33) . Remarkably, EADs were not seen at temperatures lower than 33°C. Although this study did not investigate whether HERG channel block by E-4031 was more potent at higher temperatures, other studies did not find a temperature-dependent change in the potency of E-4031 block of HERG channels (34, 35) . These data illustrate that the functional implications of I Kr reduction are greater during hyperthermia and support our postulate that failure of mutant HERG current to adequately increase at higher temperatures delays cardiac repolarization.
Finally, the increase in current density with rising temperatures was also small for the WT+F640V channels, leading to a larger difference in current density at higher temperatures compared with WT channels. We previously showed that most LQT-2-linked HERG channel mutations, including F640V, have a traffickingdeficient phenotype and impose a dominant-negative effect on WT protein trafficking (5) . Thus, although fever-induced QTc lengthening and arrhythmias for F640V or other HERG mutations are not yet reported, our experimental data suggest that a temperature-dependent phenotype may be expected for other LQT-2-linked mutations. In summary, we described fever-induced QT interval prolongation, TdP, and VF in 2 LQT-2 patients with the A558P mutation. Biochemical and biophysical analysis revealed that A558P is trafficking deficient, that it coassembles with WT subunits to cause dominant-negative behavior, and that its current density fails to increase with increasing temperature to the same extent as WT channels. Although the effects of fever on the heart are complex, our findings, together with previous experimental observations in LQTS, provide a potential mechanism that may explain the QTc lengthening with rising body temperature in our LQT-2 patients. We believe our findings demonstrate a novel arrhythmogenic mechanism for the A558P mutation at febrile temperatures, which possibly has mechanistic implications for other LQT-2-linked HERG mutations. Clearly, the role of fever in LQT-2 patients merits further investigation.
Methods
This study was approved by the local ethics committee of the Academic Medical Centre in Amsterdam, and the patients gave informed consent for participation. The investigation conforms to the principles outlined in the Declaration of Helsinki.
ECG analysis. ECG tracings were enlarged to facilitate manual analysis. QT duration (lead V5) was corrected for heart rate using Bazett's formula (QTc = QT/√RR, where RR is the interval, measured in seconds, from the onset of 1 QRS complex to the onset of the following QRS complex). The control group of patients without LQTS was admitted at the Academic Medical Centre for the treatment of a febrile episode. Two patients had pneumonia, 2 had cholangitis, 1 had toxicoderma due to omeprazole use, 1 had colitis, 1 had central venous catheter infection, and in 2 patients no cause of fever was found. Control patients had no history of cardiac disease, used no medications known to prolong the QT interval, had normal electrolytes, and had a normal cardiothoracic ratio on chest roentgenograms.
Site-directed mutagenesis. To generate the A558P and the F640V constructs, the appropriate nucleotide change (G1672C or A1918T) was engineered into WT HERG cDNA, which was then expressed in the pCDNA3 vector (Invitrogen) (5) . The mutant constructs were sequenced to verify the presence of the G1672C or A1918T substitution and to ensure the absence of other nucleotide changes.
Cell culture and transfection. HEK293 cells were cultured in Minimal Essential Medium (MEM) supplemented with 10% fetal bovine serum, penicillin, streptomycin, and nonessential amino acids. Transient transfections were performed with Superfect (QIAGEN) using 3-μg WT or mutant cDNA (homomeric channels) or 1.5-μg WT and 1.5-μg mutant cDNA (heteromeric channels). In some experiments, cells were transfected with 1.5-μg WT cDNA and 1.5-μg pCDNA3 vector. Green fluorescence protein was cotransfected to identify transfected cells under epifluorescent microscopy. The cells were incubated in 5% CO2 at 37°C, unless noted otherwise. In some experiments, 10-μmol/l E-4031 (Sigma-Aldrich; 10-mmol/l stock dissolved in distilled water) was added to the cell culture media 24 hours before experiments and washed out for 1-2 hours prior to the study. All experiments were performed 48 hours after transfection.
Western blot. Whole-cell lysates were generated by treating cell cultures of similar confluency with 1% Nonidet P-40 buffer. Equal protein amounts were measured using a Bio-Rad protein assay and mixed with SDS-PAGE sample buffer containing 5-mmol/l dithiothreitol, before heating for 15 minutes at 60°C. The proteins were then subjected to 7.5% SDS-polyacrylamide gel electrophoresis and electrophoretically transferred onto nitrocellulose membranes. The nitrocellulose membranes were incubated overnight at room temperature with a HERG C-terminal antibody and visualized using an ECL detection kit (Amersham) (16) .
Electrophysiology. HERG currents were measured using the whole-cell configuration of the patch-clamp technique with an Axopatch-200 amplifier (Axon Instruments). Pipettes were pulled with a micropipette puller (Sutter Instruments). They had a tip resistance of 3-4 MΩ when filled with pipette solution, which contained 130 mM KCl, 1 mM MgCl2, 5 mM EGTA, 5 mM MgATP, and 10 mM HEPES (pH 7.2 with KOH). The extracellular solution contained 137 mM NaCl, 4 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 10 mM glucose, and 10 mM HEPES (pH 7.4 with NaOH). Currents were filtered at 5 kHz and digitized at 10 kHz. The holding potential in all experiments was -80 mV. The voltage-clamp protocols were generated using the pCLAMP 8.0 software (Axon Instruments) and are described in the Results and Figures.
We studied the biophysical properties of WT and mutant HERG currents at 23°C, 35°C, and 40°C. Currents were first measured at 23°C, and measurements were then repeated at 35°C and 40°C for the same cell. The recording temperature in the cell perfusion chamber was directly monitored, and each temperature increase was achieved within 30 seconds using a TC 2 temperature controller (Cell MicroControls). Current densities were obtained by normalizing current amplitudes to membrane capacitance (Cm). Cm did not change at higher temperatures (14.0 ± 1.3, 15.0 ± 1.2, and 14.3 ± 1.8 at 23°C, 35°C, and 40°C, respectively). Criteria for successful experiments were (a) stable seal resistance of greater than 1 GΩ, (b) Cm and series resistance compensation greater than or equal to 80%, and (c) less than 5% rundown. Each cell was used to measure a single gating process (e.g., activation, inactivation, etc.). Measurements for all temperatures were completed within 10 minutes after obtaining intracellular access.
Statistics. Values are expressed as mean ± SEM. Linear regression and covariance analysis were used to assess the relation between QTc and body temperature in LQT-2 patients and the control group of patients without LQTS. The slopes of the linear fits were evaluated for differences from 0 and between the fits. Covariance analysis was used to determine common slopes for LQT-2 and control patients, accounting for the within patient correlation. Variance around the common slope was tested for significant differences in slope and location of the regression per group. For in vitro experiments, statistical analysis was carried out using (a) unpaired t test for comparisons of current densities between 2 different groups; (b) 1-way ANOVA repeated measures for comparisons of current densities within 1 group between different recording temperatures; or (c) 2-way ANOVA repeated measures for comparisons of gating processes. P < 0.05 (2-tailed) was considered as statistically significant.
